Loading...

Celadon Pharmaceuticals Plc

CEL.L•LSE
Healthcare
Drug Manufacturers - Specialty & Generic
£13.40
£0.00(0.00%)

Celadon Pharmaceuticals Plc (CEL.L) Company Profile & Overview

Explore Celadon Pharmaceuticals Plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Celadon Pharmaceuticals Plc (CEL.L) Company Profile & Overview

Celadon Pharmaceuticals Plc, a pharmaceutical company, engages in the research, manufacture, and supply of cannabinoids for use in approved medicines. The company focuses on growing indoor hydroponic THC cannabis for use in medicinal products used to treat chronic pain. It also intends to conduct research into cannabinoids for use in chronic pain, as well as other conditions, such as autism and multiple sclerosis. The company was founded in 2018 and is headquartered in London, the United Kingdom.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOJames Gareth Short

Contact Information

https://www.celadonpharma.co.uk
44 20 3150 0252
32-33 Cowcross Street, London, EC1M 6DF

Company Facts

27 Employees
IPO DateMar 31, 2022
CountryGB

Frequently Asked Questions

;